Download Citation
Article Source:
The Anti-Melanoma Activity of Dinaciclib, a Cyclin-Dependent Kinase Inhibitor, Is Dependent on p53 Signaling
Desai BM,
Villanueva J,
Nguyen TTK,
Lioni M,
Xiao M,
et al.
(2013)
The Anti-Melanoma Activity of Dinaciclib, a Cyclin-Dependent Kinase Inhibitor, Is Dependent on p53 Signaling.
PLOS ONE 8(3): e59588.
https://doi.org/10.1371/journal.pone.0059588